Catalyst Financial Partners LLC Dexcom Inc Transaction History

Catalyst Financial Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $9,817 - $12,500	89 Added 4.13%	2,244 $254 Million
Q1 2024 Apr 22, 2024	BUY	$114.22 - $140.1 $9,594 - $11,768	84 Added 4.06%	2,155 $288 Million
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $156,339 - $257,135	2,071 New	2,071 $257 Million
Q2 2023 Aug 02, 2023	BUY	$112.47 - $130.98 $20,694 - $24,100	184 Added 10.44%	1,946 $250 Million
Q1 2023 Apr 11, 2023	BUY	$104.0 - $122.92 $183,248 - $216,585	1,762 New	1,762 $205 Million

1,050

358M

4.11M

3.63M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Catalyst Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Financial Partners LLC with notifications on news.